title: Volume transmission-mediated encephalopathies: a possible new concept?
abstract: There is strong evidence that the composition of cerebrospinal fluid (CSF) influences brain development, neurogenesis, and behavior. The bidirectional exchange of CSF and interstitial fluid (ISF) across the ependymal and pia-glial membranes is required for these phenomena to occur. Because ISF surrounds the parenchymal compartment, neuroactive substances in the CSF and ISF can influence neuronal activity. Functionally important neuroactive substances are distributed to distant sites of the central nervous system by the convection and diffusion of CSF and ISF, a process known as volume transmission. It has recently been shown that pathologically altered CSF from patients with acute traumatic brain injury suppresses in vitro neuronal network activity (ivNNA) recorded by multielectrode arrays measuring synchronously bursting neural populations. Functionally relevant substances in pathologically altered CSF have been biochemically identified, and ivNNA has been partially recovered by pharmacologic intervention. It remains unclear whether the in vivo parenchymal compartment remains unaffected by pathologically altered CSF that significantly impairs ivNNA. We hypothesize that pathologic CSF alterations are not just passive indicators of brain diseases but that they actively and directly evoke functional disturbances in global brain activity through the distribution of neuroactive substances, for instance, secondary to focal neurologic disease. For this mechanism, we propose the new term volume transmission-mediated encephalopathies (VTE). Recording ivNNA in the presence of pure human CSF could help to identify and monitor functionally relevant CSF alterations that directly result in VTEs, and the collected data might point to therapeutic ways to antagonize these alterations.
authors.affiliation: Medical Faculty, Department of Neurology, University of Duesseldorf, Moorenstrasse 5, Duesseldorf, Germany.
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Hartung
authors.forename: Marcel
authors.initials: M
authors.lastname: Dihné
mesh_terms: D001921:Brain / Q000502:physiology / Q000503:physiopathology; D001927:Brain Diseases / Q000134:cerebrospinal fluid* / Q000503:physiopathology*; D002555:Cerebrospinal Fluid / Q000502:physiology*; D045604:Extracellular Fluid / Q000502:physiology*; D006801:Humans; D009415:Nerve Net / Q000473:pathology / Q000503:physiopathology; D058953:Neural Stem Cells / Q000502:physiology; D019581:Neuropil / Q000502:physiology; D009626:Terminology as Topic